Forward proxy - PDFSEARCH.IO - Document Search Engine

Forward proxy
Results: 85

#	Item
61	Catalyst SXC + Health Solutions CREATING A LEADING NATIONAL PROVIDER OF PBM SERVICES AND HEALTHCARE INFORMATION Add to Reading List Source URL: www.catamaranrx.com Language: English - Date: 2013-05-20 12:25:46 Forward-looking statement Mergers and acquisitions Catalysis Form 10-K Catalyst Pharmacy benefit management Sxc Government procurement in the United States Pro forma SEC filings Business Proxy statement
62	GTECH Shs' Meeting - Documentation available to the public Add to Reading List Source URL: www.gtech.com Language: English - Date: 2014-11-03 20:36:21 Financial economics Investment Proxy statement Securities Act Form 10-K Prospectus Commissione Nazionale per le Società e la Borsa GTECH Forward-looking statement SEC filings Stock market Business
63	3Q'14_Results_11-10-14_Final [Sola lettura] Add to Reading List Source URL: www.gtech.com Language: English - Date: 2014-11-10 11:56:57 Financial economics Business Securities Act Commissione Nazionale per le Società e la Borsa Form 10-K Prospectus Proxy statement Forward-looking statement Income Stock market SEC filings Finance
64	Wisconsin Energy, Integrys Energy Group schedule shareholder meetings, announce effectiveness of registration statement MILWAUKEE and CHICAGO – Oct. 6, [removed]Wisconsin Energy (NYSE: WEC) and Integrys Energy Group (NYS Add to Reading List Source URL: www.wisconsinenergy.com Language: English - Date: 2014-10-06 14:27:34 Financial economics Energy in the United States United States securities law Integrys Energy Group Securities Proxy statement Securities Act Forward-looking statement Wisconsin Energy Corporation SEC filings Stock market Business
65	GTECH press release Facilitysyndicationreduction Add to Reading List Source URL: gtech.mno01.com Language: English - Date: 2014-10-30 03:17:55 Investment Business Securities Act Commissione Nazionale per le Società e la Borsa Prospectus Proxy statement Form 10-K GTECH Forward-looking statement SEC filings Stock market Financial economics
66	International Headquarters 2150 St. Elzéar Blvd. West Laval, Quebec Canada H7L 4A8 Phone: [removed]Fax: [removed] Add to Reading List Source URL: www.valeant.com Language: English - Date: 2014-09-16 10:01:00 Business Investment Corporate finance Companies listed on the New York Stock Exchange Valeant Pharmaceuticals Proxy statement Allergan Forward-looking statement Prospectus Stock market SEC filings Financial economics
67	International Headquarters 2150 St. Elzéar Blvd. West Laval, Quebec H7L 4A8 Phone: [removed]Fax: [removed] Add to Reading List Source URL: www.valeant.com Language: English - Date: 2014-07-21 14:55:38 Finance Companies listed on the New York Stock Exchange Valeant Pharmaceuticals Financial economics Allergan J. Michael Pearson Proxy statement Bausch & Lomb Forward-looking statement Business SEC filings Stock market
68	Revised Offer for Allergan June 2, 2014 Forward-looking Statements This communication may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Canadian secur Add to Reading List Source URL: www.valeant.com Language: English - Date: 2014-06-02 13:17:30 Valeant Pharmaceuticals Allergan Proxy statement Mergers and acquisitions Generally Accepted Accounting Principles Finance SEC filings Business Companies listed on the New York Stock Exchange
69	An Unrivaled Platform for Growth & Value Creation in Healthcare Valeant Pharmaceuticals International, Inc. + Allergan, Inc. June 17, 2014 Add to Reading List Source URL: www.valeant.com Language: English - Date: 2014-06-18 08:52:21 Valeant Pharmaceuticals Allergan Finance Proxy statement Forward-looking statement Mergers and acquisitions Financial statement Business SEC filings Companies listed on the New York Stock Exchange
70	An Unrivaled Platform for Growth & Value Creation in Healthcare Valeant Pharmaceuticals International, Inc. + Allergan, Inc. Add to Reading List Source URL: www.valeant.com Language: English - Date: 2014-04-28 13:34:06 Valeant Pharmaceuticals Proxy statement Mergers and acquisitions J. Michael Pearson Forward-looking statement Schedule 13D SEC filings Business Allergan

UPDATE